Media Partners

3DPM Logo
IJB Logo
RMN colour RGB

BioPrinting: Beyond the Scaffold

October 17-18, 2016
Boston Marriott Newton – Massachusetts, U.S.A.

We emerge from the shadow of the scaffold to focus on the biology of organoids. By printing from one's own cells, each organ is more likely to be accepted by the body. But normal functioning remains the ultimate goal. We require more understanding before we can control complicated interconnected tissues, endocrine feedback systems and cell signaling networks. Please join this gathering in Boston to share perspectives as diverse as the projects ongoing, and those yet to be undertaken. Help write the next chapter in the life science story.


~Preliminary Agenda~

Dr. Vladimir Mironov
Chief Scientific Officer, 3D Bioprinting Solutions

*Dr. Ian Bellayr
Staff Fellow, Center for Biologics and Evaluation Research, U.S. Food and Drug Administration

Mr. John Bergin
Market Analyst, BCC Research

Dr. Joseph Bonventre
Chief of the Renal Unit / Director of the Bioengineering Division, Brigham and Women's Hospital and Harvard Medical School

Dr. Yong He
Laboratory of 3D Printing Process and Equipment of Zhejiang Province, China

Dr. Rosemarie Hunziker
Program Director of Tissue Engineering and Regenerative Medicine, National Institute of Biomedical Imaging and Bioengineering (NIBIB) within the National Institutes of Health (NIH) in the US Department of Health and Human Services (DHHS)

**Mr. Steve Jurvetson
Managing Director, Draper Fisher Jurvetson Venture Capital

Dr. Dongsheng Liu
Department of Chemistry Professor, Tsinghua University, China

Dr. Ibrahim Ozbolat
Associate Professor of Engineering, Penn State University

Dr. Adrian Roth
Head Mechanistic Safety, Roche Innovation Center Basel

Dr. Gordon Wallace
Director, Intelligent Polymer Research Institute, University of Wollongong

* Pending speaker liaison clearance

** Tentative


Speaking Opportunities
We are currently accepting proposals for speaker presentations through Chris Spivey at To submit a proposal, you will be asked to provide a 100-150 word summary of your proposed talk and provide your full contact details.

Proposals will be selected for oral presentations based on breakthrough implementations, use of novel advanced materials, or significance of new techniques.

We are looking for presentations discussing:

  • Engineered tissue, Co-culture, Organoids, Spheroids
  • Microfluidics, Microfabrication, Scaffolds, Robotics/automation
  • Cell lines vs. primary cultures
  • Stem cells and iPSCs
  • Lab-on-a-chip, Organ-on-a-chip
  • Screening Assay design and development
  • Target/pathway identification and validation
  • Correlation of in vitro and in vivo assays


Sponsorship, Exhibit and Workshop Opportunities can be explored by contacting Ariel Welch at